A2A Pharmaceuticals, Inc. ("A2A or "the company"), a clinical-stage pioneering biopharmaceutical company focused on developing innovative cancer therapies, today announced significant progress in its ...
"At Tampa General, our physicians and team members understand that a healthy start to life contributes to better lifelong health," said John Couris, president and CEO of Tampa General. "We are proud ...